Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer

DOI: 10.1634/theoncologist.2018-0452

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text